425: Strive Board Member Posts on X Regarding Semler Merger

Strive, Inc. board member Pierre Rochard reposted a communication on X.com concerning the proposed business combination with Semler Scientific, Inc.

Summary

• A communication was reposted on X.com by Pierre Rochard, a Board Member of Strive, Inc., on September 25, 2025.
• The communication relates to Strive's proposed business combination with Semler Scientific, Inc.
• It includes cautionary statements regarding forward-looking statements, highlighting inherent risks and uncertainties associated with the transaction.
• The filing details various risks that could cause actual results to differ materially from anticipated outcomes.
• Information is provided on where to find additional relevant documents filed with the SEC, including the upcoming Registration Statement on Form S-4.
• Strive and Semler Scientific, along with certain directors, executive officers, and employees, may be deemed participants in the solicitation of proxies from Semler Scientific stockholders.
• The communication explicitly states it is not an offer to sell or solicit an offer to buy any securities or a solicitation of any vote of approval.

Sentiment

Score: 5

Explanation: The filing is a standard legal disclosure for a proposed merger, heavily emphasizing risks and cautionary language. While the underlying merger intent is strategic, the document itself is procedural and risk-focused, leading to a neutral sentiment.

Positives

• The proposed business combination between Strive, Inc. and Semler Scientific, Inc. is intended to yield strategic and financial benefits for the combined company.

Risks

• The merger agreement between Strive and Semler Scientific could be terminated due to various events, changes, or circumstances.
• The proposed transaction may not close as expected or at all if conditions to closing are not met or satisfied on a timely basis.
• Legal proceedings may be instituted against Strive, Semler Scientific, or the combined company, impacting the transaction.
• Anticipated benefits of the proposed transaction, including cost savings and strategic gains, may not be realized as expected or at all.
• Risks are associated with the implementation of Bitcoin treasury strategies and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and regulatory changes could adversely affect the transaction's benefits.
• The integration of the two companies may be more difficult, time-consuming, or costly than anticipated.
• The proposed transaction may be more expensive or take longer to complete than expected due to unforeseen factors.
• Management's attention may be diverted from ongoing business operations and opportunities during the merger process.
• Strive's issuance of additional shares of its Class A common stock in connection with the transaction could cause dilution.
• Potential adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships may occur.
• Changes in Strive's or Semler Scientific's share price before closing could impact the transaction.
• Other unknown or unpredictable factors could harm the results of Strive, Semler Scientific, or the combined company.

Future Outlook

The outlook and expectations of Strive and Semler Scientific regarding the proposed transaction include anticipated strategic and financial benefits, successful integration of combined businesses, and a timely closing. However, these are forward-looking statements subject to significant risks and uncertainties, and actual results may differ materially from these projections.

Management Comments

• Pierre Rochard, a Board Member of Strive, Inc., reposted the communication on X.com regarding the proposed business combination.
• Management of Strive and Semler Scientific hold opinions and judgments about future events, including the strategic and financial benefits of the proposed transaction, the timing of closing, and the ability to successfully integrate the combined businesses.

Industry Context

The proposed business combination and the explicit mention of 'Bitcoin treasury strategies' indicate a strategic move by the combined entity to potentially integrate digital assets into its corporate financial management, aligning with a growing trend among some companies to explore alternative treasury management approaches.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is a potential risk to the proposed transaction.

Stakeholder Impact

• Shareholders of Strive may experience dilution due to the issuance of additional Class A common stock in connection with the merger.
• Stockholders of Semler Scientific will be required to approve the proposed transaction.
• Customers of both Strive and Semler Scientific may have adverse reactions to the proposed transaction.
• Employee relationships at both companies could change as a result of the announcement or completion of the proposed transaction.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC to register the Class A common stock to be issued in connection with the proposed transaction.
• The Registration Statement will include an Information Statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific to seek their approval of the proposed transaction.
• Investors and stockholders of Semler Scientific are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available, along with other relevant SEC documents.

Key Dates

Recommendation

The filing is a procedural communication regarding a proposed business combination, emphasizing associated risks and future disclosures. It lacks new financial performance data or definitive strategic updates to warrant a strong buy or sell recommendation. Investors should hold and await the full Registration Statement on Form S-4 and Information Statement/Proxy Statement/Prospectus for a comprehensive understanding of the transaction's financial and strategic implications before making further investment decisions.

Keywords

Strive Inc, Semler Scientific Inc, Merger, Business Combination, SEC Filing, Form 425, Bitcoin Treasury, Corporate Governance, Risk Management, Forward-Looking Statements